Wedbush Maintains an 'Outperform' on Chelsea Therapeutics (CHTP); Enthusiastic About Northera As A Better Treatment For NOH
Tweet Send to a Friend
Wedbush maintains an 'Outperform' on Chelsea Therapeutics (NASDAQ: CHTP), PT $8.
Wedbush analyst says, "In our conversations and in their ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "In our conversations and in their ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
